RoE Travel Vaccine Market to 2032
Overview
The RoE Travel Vaccine Market is expected to reach a 87.23 USD Million by 2032 and is projected to grow at a CAGR of 8.39% from 2025 to 2032.
Revenue, 2024 (USD Million)
52.34
Forecast, 2032 (USD Million)
87.23
CAGR, 2024 - 2032
8.39%
Report Coverage
RoE
RoE Travel Vaccine Market 2018-2032 USD Million
RoE Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 52.34 USD Million
- Projected Market Size (2032): 87.23 USD Million
- CAGR (2025-2032): 8.39%
Key Findings of RoE Travel Vaccine Market
- The RoE Travel Vaccine Market was valued at 52.34 USD Million in 2024.
- The RoE Travel Vaccine Market is likely to grow at a CAGR of 8.39% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 43.03 USD Million
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 17.44% during the forecast period from 2024 to 2032.
RoE Travel Vaccine Market Scope
RoE Travel Vaccine Market Segmentation & Scope
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Route of Administration
- Oral
- Injectable
RoE Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 52.34 USD Million |
| Market Value in 2032 | 87.23 USD Million |
| CAGR (2025-2032) | 8.39% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Composition,Distribution Channel,Age Group,Patient Type,Gender,Category,Disease,Route of Administration |
Regional Insights:
-
Leading Market (2024-2032): RoE, leading in terms of revenue 52.34 USD Million in 2024
- Key Country: RoE, leading in terms of revenue with value of 52.34 USD Million in 2024.
Segments and Scope
-
RoE Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in RoE Travel Vaccine Market to 2032 with a revenue of 15.68 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in RoE Travel Vaccine Market to 2032 with a Growth rate of 9.42 % in forecast period 2025-2032.
-
RoE Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in RoE Travel Vaccine Market to 2032 with a revenue of 36.33 USD Million in the year 2024.
- Combination Vaccines is the Fastest growing segment in RoE Travel Vaccine Market to 2032 with a Growth rate of 8.54 % in forecast period 2025-2032.
-
RoE Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in RoE Travel Vaccine Market to 2032 with a revenue of 40.77 USD Million in the year 2024.
- B2B is the Fastest growing segment in RoE Travel Vaccine Market to 2032 with a Growth rate of 8.55 % in forecast period 2025-2032.
-
RoE Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in RoE Travel Vaccine Market to 2032 with a revenue of 26.65 USD Million in the year 2024.
- 20-50 Years is the Fastest growing segment in RoE Travel Vaccine Market to 2032 with a Growth rate of 8.83 % in forecast period 2025-2032.
-
RoE Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in RoE Travel Vaccine Market to 2032 with a revenue of 24.37 USD Million in the year 2024.
- Adult is the Fastest growing segment in RoE Travel Vaccine Market to 2032 with a Growth rate of 9.00 % in forecast period 2025-2032.
-
RoE Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in RoE Travel Vaccine Market to 2032 with a revenue of 28.05 USD Million in the year 2024.
- Male is the Fastest growing segment in RoE Travel Vaccine Market to 2032 with a Growth rate of 8.60 % in forecast period 2025-2032.
-
RoE Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in RoE Travel Vaccine Market to 2032 with a revenue of 25.09 USD Million in the year 2024.
- Recommended Vaccine is the Fastest growing segment in RoE Travel Vaccine Market to 2032 with a Growth rate of 8.79 % in forecast period 2025-2032.
-
RoE Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in RoE Travel Vaccine Market to 2032 with a revenue of 7.43 USD Million in the year 2024.
- Typhoid is the Fastest growing segment in RoE Travel Vaccine Market to 2032 with a Growth rate of 17.44 % in forecast period 2025-2032.
-
RoE Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in RoE Travel Vaccine Market to 2032 with a revenue of 43.03 USD Million in the year 2024.
- Injectable is the Fastest growing segment in RoE Travel Vaccine Market to 2032 with a Growth rate of 8.53 % in forecast period 2025-2032.
RoE Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
RoE Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million
RoE Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoE Travel Vaccine Market is segmented based on Segmentation Type,Composition,Distribution Channel,Age Group,Patient Type,Gender,Category,Disease,Route of Administration.
RoE Travel Vaccine Market was valued at USD 52.34(Revenue in USD Million) in 2022.
RoE Travel Vaccine Market is projected to grow at a CAGR of 8.39% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the RoE Travel Vaccine Market, holding a largest market share of 43.03 USD Million in 2024
RoE Travel Vaccine Market Scope
RoE Travel Vaccine Market Segmentation & Scope
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Route of Administration
- Oral
- Injectable
Frequently Asked Questions
The RoE Travel Vaccine Market is segmented based on Segmentation Type,Composition,Distribution Channel,Age Group,Patient Type,Gender,Category,Disease,Route of Administration.
RoE Travel Vaccine Market was valued at USD 52.34(Revenue in USD Million) in 2022.
RoE Travel Vaccine Market is projected to grow at a CAGR of 8.39% during the forecast period of 2024 to 2032.
The estimated market value of the RoE Travel Vaccine Market for final year is USD 87.23 (USD Million).
RoE Travel Vaccine Market Company Profiling
Frequently Asked Questions
The RoE Travel Vaccine Market is segmented based on Segmentation Type,Composition,Distribution Channel,Age Group,Patient Type,Gender,Category,Disease,Route of Administration.
RoE Travel Vaccine Market was valued at USD 52.34(Revenue in USD Million) in 2022.
RoE Travel Vaccine Market is projected to grow at a CAGR of 8.39% during the forecast period of 2024 to 2032.
The estimated market value of the RoE Travel Vaccine Market for final year is USD 87.23 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.